Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02981706 · ClinicalTrials.gov registry record · NA
Comparison of AVF Versus AVG in Elderly Patients Starting Dialysis
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT02981706 is a NA study that has completed, run by Columbia University. The registered enrollment target is 20 participants.
The verdict
NCT02981706, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This is a pilot, single-center, randomized trial of 90 subjects to evaluate complication rates and functional status decline in subjects age 65 years and older referred for vascular access placement. Subjects will be randomized to arteriovenous fistula (AVF) (n = 45) versus arteriovenous graft (AVG) (n = 45), placed in a vascular access monitoring protocol, and undergo measurements of functional status including gait speed, grip strength, and self-reported function over 6 months. The primary hypothesis to be tested is that AVF placement will result in a higher proportion of primary access failure as defined by a binary composite primary endpoint of an unsalvageable access or an immature access or a non-functional access measured at 6 months compared to AVG placement. In addition, the study will evaluate whether AVF placement and a greater number of access procedures will result in a greater decline in functional status as measured by the average change over 6 months in gait speed, grip strength, and self-reported function as assessed by the Disabilities in Arm, Shoulder and Hand Survey.
Interventions
- PROCEDURE Arteriovenous Fistula (AVF)
- PROCEDURE Arteriovenous Graft (AVG)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2016-10-06 |
| Est. Completion | 2019-02-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02981706
The ClinicalTrials.gov registry entry for NCT02981706 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Arteriovenous Fistula (AVF) is the first listed.
NCT02981706 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02981706 about?
NCT02981706 is a clinical study titled "Comparison of AVF Versus AVG in Elderly Patients Starting Dialysis". This is a pilot, single-center, randomized trial of 90 subjects to evaluate complication rates and functional status decline in subjects age 65 years and older referred for vascular access placement. Subjects will be randomized to arteriovenous fistula (AVF) (n = 45) versus arteriovenous graft (AVG)...
What is the current status of trial NCT02981706?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2016-10-06. Estimated completion is 2019-02-15.
What interventions are being tested in trial NCT02981706?
The interventions under investigation include: Arteriovenous Fistula (AVF) (PROCEDURE), Arteriovenous Graft (AVG) (PROCEDURE).
Who is sponsoring clinical trial NCT02981706?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.